Mental Health Clinics in Spring Grove, PA Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Dgb Behavioral Health Llc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 1287 Village Drive, Spring Grove, PA 17362 Phone: 717-225-5916 |
News Archive
Biolauncher, Isogenica and Cresset enter joint venture to develop drug discovery platform
Isogenica Ltd today announced a collaborative joint venture with Biolauncher Ltd and Cresset Biomolecular Discovery Ltd to develop an innovative end-to-end therapeutic discovery platform.
Breakthrough in cell-type analysis offers new ways to study development and disease
Like skilled assassins, many diseases seem to know exactly what types of cells to attack. While decimating one cadre of cells, diseases will inexplicably spare a seemingly identical group of neighbors. What makes cells vulnerable or not depends largely on the kinds and amounts of proteins they produce - their 'translational profile,' in the lingo of molecular biology. For this reason, scientists have struggled to parse the subtle molecular differences among the hundreds of specialized cell types that are tangled together in tissues like the brain.
Study: Pseudokinases can play a crucial role in pathogen-based disease
Researchers from the University of Pittsburgh and Stanford University discovered that a supposedly inactive protein actually plays a crucial role in the ability of one the world's most prolific pathogens to cause disease, findings that suggest the possible role of similarly errant proteins in other diseases.
Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
Discovery may pave way for immunotherapies for prostate cancer
Using a common chemotherapy agent, researchers at UCLA's Jonsson Cancer Center and the Department of Pathology and Laboratory Medicine found a way to move an important biomarker expressed in prostate cancer, shaking it loose from one location in a cell – where it could not be accessed by blood – to another, easier to target area.
› Verified 5 days ago